Objectives: There has been little systematic study of emergency department (ED) patients with elevated blood pressure (BP) values. The authors sought to characterize ED patients with elevated BP values, assess presenting symptoms, and determine the prevalence of elevated BP after discharge. Methods: This was a cross-sectional study performed in four academic EDs. Adults presenting with systolic BP $140 mm Hg or diastolic BP $90 mm Hg were enrolled over a one-week equivalent period. Demographics, medical history, and symptoms were obtained by chart abstraction and structured interview. A random patient subset underwent a three-week follow-up interview. BP measurements were staged, using Joint National Committee on Prevention, Detection, Evaluation, One in four adults in the United States has hypertension, defined as sustained diastolic blood pressure (BP) $90 mm Hg, systolic BP $140 mm Hg, or use of antihypertensive medications to maintain acceptable BP values.
One in four adults in the United States has hypertension, defined as sustained diastolic blood pressure (BP) $90 mm Hg, systolic BP $140 mm Hg, or use of antihypertensive medications to maintain acceptable BP values. 1 As a major contributor to cerebrovascular, cardiovascular, and renal disease, hypertension has been extensively studied in stable outpatients. Early identification and systematic management of BP have been shown to reduce long-term hypertension-related complications in outpatient settings. [2] [3] [4] [5] [6] Characteristics of hypertensive individuals are well defined, and evidence-based approaches to the assessment and management of outpatients with elevated BP values have been widely circulated.
There has been surprisingly little systematic study of patients presenting to the emergency department (ED) with elevated BP values. Controversy surrounds the ED evaluation and management of patients with hypertension, and the approach to ED patients with elevated BP values is generally not evidence based. 7 Emergency medicine references routinely incorporate hypertension management principles derived from guidelines intended for primary care practitioners concerned with the long-term management of stable outpatients. 8 These guidelines may not be appropriately applied to patients in the ED setting. Furthermore, the ED is frequently the only opportunity for many individuals, particularly those who are economically disadvantaged, to come in contact with health care providers. 9 While BP screening in the ED has been recommended as effective for early detection and successful referral of hypertensive patients, these recommendations seem to be based on the results of small studies. 10 A few studies have examined the characteristics of ED patients with severely elevated BP values, 11 -13 yet we are unable to identify published descriptions of ED patients with milder degrees of BP elevation.
To provide a foundation for study of hypertension in ED patients, we performed a cross-sectional, multicenter study of patients noted to have elevated BP values during their ED visit. We attempted to characterize these patients through structured interviews and contemporaneous abstraction of medical record data. We assessed the symptoms precipitating the ED visits of patients with elevated BP values and the prevalence of symptoms commonly regarded as being associated with hypertension. Using follow-up telephone interviews in a random sample of our study patients, we sought to determine the frequency with which elevated BP values persist following discharge from the ED.
METHODS
Study Design. This was a cross-sectional, observational cohort study of consecutive patients with elevated BP values presenting to one of four academic EDs during a one-week period. The study was approved by the institutional review board of each participating site.
Study Setting and Population. The study was conducted during the summer and fall of 2002. The characteristics of the participating sites are shown in Table 1 . All participating sites are located in inner-city areas, serve largely economically disadvantaged patients, and are primary teaching hospitals of medical schools. All are staffed primarily or exclusively by physicians who are board certified or board eligible in emergency medicine. Three of the four sites support emergency medicine residency training programs, and all have residents from non-emergency medicine specialties. The combined annual census of the participating sites was 376,000.
Study Protocol. Patients were eligible for the study if they were at least 18 years old, presented to the ED with any complaint during the data collection periods, and had a diastolic BP $90 mm Hg or systolic BP $140 mm Hg at any time during the ED visit.
Patients with known hypertension were eligible for enrollment. The only exclusion to enrollment was inclusion as a study subject during a previous ED visit. The vital signs of all patients present in the ED were reviewed every two hours during study periods; patients were enrolled if any BP measurement met study criteria.
Each site screened and enrolled study patients for the equivalent of one week. To facilitate data collection, research associates were present during predetermined, discontinuous eight-hour periods scheduled such that each time and day of the week was sampled once over a two-week period. Dedicated research associates, not blinded to the study hypothesis, were trained in study data collection, human subject protection requirements, and good clinical research practices. The associates had no clinical patient care responsibilities during the data collection periods. Site coordinators maintained enrollment logs in which they recorded each patient screened, reasons for nonenrollment, and whether the patient consented to be interviewed. Physicians and nurses in the ED were blinded to the nature of the study, and patients were not enrolled when site investigators were on duty.
No change in routine patient care was required by the study protocol. To avoid altering patient management practices, no attempt was made to standardize BP measurement techniques for the study, which were performed by staff ED nurses according to each site's nursing guidelines. Measurements were generally made using an automated device, with the patient in a seated position, unless the patient was immediately placed on a stretcher. The devices varied between sites and were calibrated before study initiation according to the manufacturer's specifications.
Measurements. Data routinely available from the medical records of enrolled subjects were recorded on a standardized data abstraction form. Abstracted data included demographic information and the presenting complaint as recorded on the nursing record (by the triage nurse or the nurse first encountering the patient). If multiple complaints were listed, the first listed complaint was recorded as the chief complaint. Additional data abstracted from the medical record included all subsequent BP measurements, whether specific testing was performed and the results of the test, medications administered, the patient's final disposition, and, if the patient was discharged, the medications prescribed and whether the patient received specific written instructions regarding his or her elevated BP. As soon as practical after the patient's initial ED assessment and stabilization, the research associates approached the patient and sought consent to perform a detailed, structured interview. The interview included closed-ended questions related to the patient's current and recent symptoms, medical history, prescribed medications and medication compliance, and recent illicit substance use. Patients were asked if they had experienced, within 24 hours of arrival in the ED, any of the symptoms considered by most authorities to be suggestive of acute hypertension-related end-organ damage. 2, 7, 12, 14, 15 These symptoms, which each patient was asked to endorse if present, included chest pain, dizziness, shortness of breath, unilateral weakness or numbness, change in mental status or confusion, headache, nosebleed, hematuria, or visual changes.
The interview form was developed using the nominal group technique, in which a group of study authors created questions after a detailed review of prior studies, expert reviews, and textbook guidelines for the management of hypertension in the ED setting. 1, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] The survey instrument underwent pilot testing at a single study site, during which it was administered to 294 ED patients with elevated BP values. Questions were then modified to address any ambiguities. Data from the pilot phase were not included in the analysis. Patients who were critically ill or severely injured were not interviewed unless they became stable and seemed comfortable. When the patient was noncommunicative or disoriented, a guardian or caretaker was approached for the interview and the interview was not performed if no such individual was available. Spanish-speaking patients were interviewed by interpreters using professionally translated questionnaires.
Patients who agreed to be interviewed were asked to provide additional consent to receive a follow-up telephone call three weeks after the ED visit. Fifty percent of interviewed subjects at each site were randomly selected to receive follow-up telephone calls, using a table of random numbers. Multiple attempts were made to reach the selected follow-up candidates, including calls to the patients' home and work and alternate telephone numbers provided by the patients. At least three separate attempts were made to reach each follow-up candidate, with calls placed at different times of the day and evening. Those contacted underwent a brief structured interview regarding medical evaluations subsequent to the index ED visit and compliance with prescribed medication. The followup interview was developed in the manner described previously for the ED interview. There was no attempt made to provide standardized discharge instructions mandating follow-up for patients noted in the ED to have elevated BP values.
Data collection instruments were reviewed daily for completeness by a site investigator. Missing elements of the data abstraction forms were obtained, when appropriate, by review of the ED record. Completed forms were stripped of any patient identifiers and delivered to a central site for coding and data entry.
Data Analysis. Subjects were grouped into BP stages using the criteria contained in the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI), as listed in Table 2 .
8 These criteria were current at the time the study was performed, they are widely incorporated into the emergency medicine literature, and their definitions of BP stages are familiar to most physicians. 14, 15 If multiple BP measurements were performed, the greatest systolic or diastolic BP value recorded in the ED was used as the grouping criterion. Data were analyzed using SAS version 9.1.3 (SAS Institute, Inc., Cary, NC) and SPSS version 12.0 (SPSS Inc., Chicago, IL). Descriptive statistics were generated for patients' demographic characteristics; results are presented as means 6 standard deviations. Differences across BP stages were then compared using chi-square analyses, analysis of variance, and the Cochran-Armitage trend test. Yates' correction, portioning of the chi-square test, and Fisher's exact test were applied as appropriate. [16] [17] [18] All statistical analyses were two tailed and considered significant at the p # 0.05 level.
RESULTS
A patient enrollment flow diagram is presented in Figure 1 . During the one-week cumulative enrollment period, 7,238 patients presented to the participating sites and 1,441 patients fulfilled criteria for study enrollment. Forty-five screened patients were not enrolled for the reasons listed in Figure 1 . Thus, 1,396 patients are included in final analyses, representing 19.3% of patients presenting to the participating sites during the study period. Table 2 shows the JNC-VI BP staging criteria and the distributions of study patients' BP measurements, grouped according to the highest BP measurement noted during the ED stay. The BP measurements of 854 patients (61.2%) were repeated at least 30 minutes after the initial measurement qualifying the patient for the study. Among those with repeated BP measurements, the BP stage increased in 92 (10.8%), remained the same in 346 (40.5%), and decreased in 416 (48.7%).
Characteristics of enrolled patients are shown in Table 3 . The predominance of African American and Hispanic study subjects (63.1% and 21.6% of the total, respectively) is consistent with the overall ethnic composition of patients seen at the participating EDs. The high rate of uninsured subjects (46.6%) also reflects the payer mix at the participating sites. The chief complaints cited by study patients upon ED presentation are listed in Table 4 . Statistically Table 5 shows the frequency with which interviewed subjects endorsed having specific hypertension-associated symptoms within 24 hours of ED presentation. A total of 422 interviewed patients (47.7%) stated that they were currently under a physician's care for hypertension treatment, 375 (88.9%) of whom stated they were presently prescribed an antihypertensive medication. Among those currently prescribed antihypertensive medication, 158 (42.1%) stated that they had missed at least one dose of their medication within the prior 24 hours. Half of the interviewed subjects were randomly selected to receive a follow-up telephone interview within three weeks of the study ED visit, of whom 334 (74.7%) were successfully contacted. A total of 211 patients (63.2%) reported having seen a primary care practitioner since ED discharge; this rate did not vary by BP severity or whether BP values remained elevated with serial measurement in the ED. Fifty-five patients (26.1%) reported being told that their BP was elevated at follow-up, 122 (57.8%) stated that their BP was normal, five (2.4%) recalled being told it was low, and the remaining five patients (13.7%) did not remember having a discussion of their BP or stated that their BP was not addressed. Patients with greater degrees of BP elevation in the ED were more likely to be told that their BP was elevated at the time of the follow-up visit ( 
DISCUSSION
Hypertension is highly prevalent in the United States, affecting 50 million individuals, or one fourth of the adult population. An extensive body of clinical trials has established that early identification, evaluation, and management of patients with hypertension results in reduction in cardiovascular disease, stroke, and renal disease. 19 Despite the attention given hypertension in the general population, there has been surprisingly little systematic study of ED patients with elevated BP values. An emergency medicine public health task force recommends hypertension screening and referral as a successful preventive medical care strategy in the ED setting, yet the evidence for this recommendation seems limited.
9,10 Although a small study published in 1987 found that the majority of ED patients with elevated BP values had no history of hypertension and remained hypertensive at followup, the poor response rate and outdated hypertension criteria require that further investigation be performed before the utility of screening ED patients for hypertension can be confirmed. 20 We have found elevated BP values to be highly prevalent among patients presenting to the EDs participating in this observational study. Approximately one in five adult ED patients presenting during the study period had abnormally high BP values at some time during his or her ED visit. Although elevated BP values have been shown to spontaneously normalize over time, 21 we have found that the BP stage declines in fewer than half of ED patients with elevated BP values who have serial measurements performed. This suggests that an elevated BP value in an ED patient should not be discounted as a transient phenomenon.
Half of the ED patients in our study who were noted to have elevated BP values reported that they were not presently under medical care for hypertension. The majority of this group stated that they had never been told that they had high BP. This supports the argument that the ED visit may be an appropriate venue to screen patients for undiagnosed hypertension, and to refer individuals with elevated BP values to primary care practitioners for further evaluation and management. Our data suggest that BP screening in the ED may falsely identify many individuals as hypertensive. However, ED-based BP screening programs come at no incremental cost to the ED or to the patient, because BP is routinely measured in all ED patients, and advising patients with abnormal vital signs to follow up with a primary medical physician is considered a standard of medical care. 14, 15 Although we did not attempt to calculate the cost of falsely identifying ED patients as having hypertension, expert groups widely recommend BP screening in nontraditional settings in which false positives would be expected to be equally likely. 1 Medication noncompliance seems to be an important factor in a large portion of ED patients noted to have abnormally elevated BP values. Among those with elevated BP who were prescribed an antihypertensive medication, almost half reported that they had recently missed a scheduled medication dose. Identification of patients with inadequately managed disease and referral to a primary care physician for counseling may be another benefit of routinely addressing elevated BP values in the ED, at no incremental cost to the ED or to the patient.
Among those patients who were followed up at three weeks and reported seeing a primary care physician after ED discharge, one fourth reported that their BP remained elevated. The rate of persistently elevated BP following ED discharge has been previously reported to be as high as 70%. 22 That investigation, unlike ours, enrolled patients both from the ED and from an urgent care center and retrospectively reviewed computerized records rather than relying on patient reports. Despite these differences, both studies showed that it is not uncommon for elevated BP values noted in the ED to remain elevated at the time of follow-up. This lends further support to the argument that even mildly elevated BP values in ED patients should not be discounted.
Chest pain, dyspnea, dizziness, focal neurologic deficit, mental status change, headache, epistaxis, and hematuria may reflect acute hypertensive endorgan dysfunction in patients with elevated BP values. 7, 8, 12, 14, 15 These are commonly referred to as ''hypertension-associated symptoms,'' and their presence is suggestive of a hypertensive emergency. In our study, one third of all ED patients with elevated BP values presented with one of these symptoms as their chief complaint. Because these complaints were extracted from the medical record and not prompted by study investigators, it is unlikely that recall bias affected this finding. Almost 90% of interviewed patients endorsed having at least one ''hypertension-associated symptom'' in the 24 hours before ED presentation. It has been argued that these symptoms are too common and nonspecific in ED patients to be reliable indicators of acute hypertensive end-organ dysfunction. Some prior investigations and expert reviews question the relationship between BP value and the symptoms commonly regarded as indicative of a hypertensive emergency. 7, 23 Our study found dyspnea to be significantly more common among patients with more severely elevated values. This difference is seen both when symptoms are assessed by abstraction of presenting complaints and when assessed by structured patient interviews, and it is therefore unlikely to be an artifact of the study design. We have noted the association between shortness of breath and BP value in a previous study. 23 A recent investigation found that patients with normal ejection fractions and hypertension-related pulmonary edema had transient diastolic dysfunction that resolved when their BP normalized. 24 It is possible that some degree of pulmonary edema is responsible for the dyspnea noted in our study patients with greater degrees of BP elevation. Further study is necessary of a possible causal relationship between BP and dyspnea. We also found epistaxis to be a more common chief complaint among patients with greater BP values in the ED. This finding is consistent with results of prior investigations. 25, 26 
LIMITATIONS
There are several important limitations to this study. This was intended to be an exploratory, hypothesisgenerating study, rather than a hypothesis-testing study. We have presented our results as multiple unadjusted analyses, not controlling for possible confounding or interactions. Stronger conclusions regarding any of the specific intergroup differences noted in our study would require use of a multivariate model.
We enrolled patients at inner-city EDs that serve predominantly African American and Hispanic patients and have a high proportion of uninsured patients. It is known that hypertension is more prevalent in African American individuals than in nonHispanic white individuals. 1, 8, 16 Our findings may not be generalizable to other practice settings.
Measurement of BP in our study was not performed in a standardized fashion. An attempt to mandate BP measurement techniques would have disclosed the nature of our study to the treating physicians and nurses, altering the patients' medical management and confounding our attempt to perform an observational study. It is possible that BP values would have normalized had standardized BP measurement techniques and repeat assessments been required, although this was not noted in the subset of study patients who had repeated BP assessment. We believe that the BP measurement techniques used in our study reflect common ED practice, and the value of an effective screening program relies heavily on the ease with which target patients can be identified.
Data regarding presenting symptoms were derived both from the ED record and from structured patient interviews; responses derived from each source were analyzed separately. Questioning patients about hypertension-related symptoms may introduce recall or elicitation bias from the patient and bias from the interviewer. Abstraction of complaints from the medical record may provide limited or inaccurate information. The use of two sources of data regarding the patients' symptoms was selected to provide complementary information. Although our questionnaire was extensively pilot tested and revised, there is no criterion standard by which to assess its validity.
Subject interviews were performed in a subset of patients who agreed to provide written consent for this phase of the study. The interviewed patients differed significantly from the noninterviewed subjects in ethnicity, age, insurance status, and BP stage. It is possible that Hispanic subjects were less likely to consent to be interviewed because of language barriers.
Our study called for intensive efforts to be made in obtaining follow-up interviews in a randomly selected subset of consenting patients. We were able to contact the majority of this group. We did not attempt to obtain further information on those who could not be contacted by telephone, and it is possible that this subset had short-term outcomes that differed from those who could be reached. It is also possible that by participating in our study, patients were more attentive to their BP, more likely to follow-up after ED discharge, or more likely to address their BP in a follow-up medical encounter. We relied on the patients' report of their BP at the time of their follow-up visit, which may be subject to recall error or bias. Further investigations may focus on carefully verifying whether BP value is sustained following ED discharge.
CONCLUSIONS
We found elevated BP values to be common in patients presenting to inner-city EDs. African American patients were more likely than other ethnic groups to have greater BP values in the ED. Half of ED patients with elevated BP values had no history of hypertension. Among those who followed up with a primary care practitioner after ED discharge, one fourth reported that their BP values were still elevated. Symptoms commonly regarded as being suggestive of hypertensive end-organ damage are very common among ED patients with high BP values, and there seems to be a strong association between BP stage and complaints of dyspnea. Our findings support the assertion that the ED may be an appropriate location for identifying previously undiagnosed or inadequately treated hypertensive individuals and referring them for further evaluation, although such a screening program would have a high false-positive rate.
